EUVIMEDEUVIMED entdecken
Crossref

MED13L and its disease‐associated variants influence the dendritic development of cerebral cortical neurons in the mammalian brain

Nanako Hamada, Ikuko Iwamoto, Koh-Ichi Nagata iD

Journal of Neurochemistry · 2023

DOI: 10.1111/jnc.15783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2023. Verfasst von Nanako Hamada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Japan. Hauptthemen laut MEDLINE: Intellectual Disability, Mediator Complex, Neurons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mediator complex comprises multiple subcellular subunits that collectively function as a molecular interface between RNA polymerase II and gene‐specific transcription factors. Recently, genetic variants to one subunit of the complex, known as MED13L (mediator complex subunit 13 like), have been implicated in syndromic intellectual disability and distinct facial features, frequently accompanied by congenital heart defects. We investigated the impact of five disease‐associated MED13L variants on the subcellular localization and biochemical stability of MED13L protein in vitro and in vivo. In overexpression assays using cortical neurons from embryonic mouse cerebral cortices transduced by in utero electroporation‐mediated gene transfer, we found that mouse orthologues of human MED13L‐p.P866L and ‐p.T2162M missense variants accumulated in the nucleus, while the p.S2163L and p.S2177Y variants were diffusely distributed in the cytoplasm. In contrast, we found that the p.Q1922* truncation variant was barely detectable in transduced cells, a phenotype reminiscent of this variant that results in MED13L haploinsufficiency in humans. Next, we analyzed these variants for their effects on neuronal migration, dendritic growth, spine morphology, and axon elongation of cortical neurons in vivo. There, we found that overexpression of the p.P866L variant resulted in reduced number and length of dendrites of cortical layer II/III pyramidal neurons. Furthermore, we show that mMED13L‐knockdown abrogated dendritic growth in vivo, and this effect was significantly rescued by co‐electroporation of an RNAi‐resistant mMED13L, but weakly by the p.T2162M variant, and not at all by the p.S2163L variant. However, overexpression of the p.S2163L variant inhibited mature dendritic spine formation in vivo. Expression of each of the 5 variants did not affect neuronal cell migration and callosal axon elongation in vivo. Taken together, our results demonstrate that MED13L expression is relevant to corticogenesis and influences the dendritic branching characteristics of cortical excitatory neurons. Our study also suggests that disease‐associated MED13L variants may directly cause morphological and functional defects in cortical neurons in different ways. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityMediator ComplexNeuronsAnimalsHumansMiceBrainCerebral CortexMammalsPhenotypeTranscription Factors

Stichwörter der Autor:innen

MED13Lcortical neurondendritemediator complexpathogenic variations

Substanzen

MED13L protein, humanMediator ComplexTranscription FactorsMed13l protein, mouse

Autor:innen und Institutionen

  • Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Japan.
  • Department of Neurochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID-Profile: Koh-Ichi Nagata

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Hamada, N., Iwamoto, I., & Nagata, K. I. (2023). MED13L and its disease‐associated variants influence the dendritic development of cerebral cortical neurons in the mammalian brain. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15783

Vancouver

Hamada N, Iwamoto I, Nagata KI. MED13L and its disease‐associated variants influence the dendritic development of cerebral cortical neurons in the mammalian brain. Journal of Neurochemistry. 2023. doi:10.1111/jnc.15783

BibTeX
@article{Hamada2023,
  author = {Hamada, Nanako and Iwamoto, Ikuko and Nagata, Koh-Ichi},
  title = {MED13L and its disease‐associated variants influence the dendritic development of cerebral cortical neurons in the mammalian brain},
  journal = {Journal of Neurochemistry},
  year = {2023},
  doi = {10.1111/jnc.15783}
}
Kostenlos starten →